Literature DB >> 19702449

Costs of hormonal and nonhormonal prescription medications for hot flashes.

Amie Williams-Frame1, Janet S Carpenter.   

Abstract

Hot flashes are the cardinal symptom of menopause and can be treated with hormonal and nonhormonal prescription medications. However, considering that 6000 women enter menopause daily in the USA, and many of these women are symptomatic, the costs of these treatments can be a significant public health issue. We evaluated annual individual and population costs of hormonal and nonhormonal prescription treatments for hot flashes. Cost information may be helpful to clinicians and consumers in making treatment decisions.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19702449      PMCID: PMC3637932          DOI: 10.2217/whe.09.49

Source DB:  PubMed          Journal:  Womens Health (Lond)        ISSN: 1745-5057


  15 in total

1.  Venlafaxine is superior to clonidine as treatment of hot flashes in breast cancer patients--a double-blind, randomized study.

Authors:  S Loibl; K Schwedler; G von Minckwitz; R Strohmeier; K M Mehta; M Kaufmann
Journal:  Ann Oncol       Date:  2007-01-17       Impact factor: 32.976

2.  Strategies and issues for managing menopause-related symptoms in diverse populations: ethnic and racial diversity.

Authors:  Valerie Montgomery Rice
Journal:  Am J Med       Date:  2005-12-19       Impact factor: 4.965

3.  Estrogen and progestogen use in postmenopausal women: July 2008 position statement of The North American Menopause Society.

Authors:  Wulf H Utian; David F Archer; Gloria A Bachmann; Christopher Gallagher; Francine n Grodstein; Julia R Heiman; Victor W Henderson; Howard N Hodis; Richard H Karas; Rogerio A Lobo; JoAnn E Manson; Robert L Reid; Peter J Schmidt; Cynthia A Stuenkel
Journal:  Menopause       Date:  2008 Jul-Aug       Impact factor: 2.953

4.  Oral clonidine in postmenopausal patients with breast cancer experiencing tamoxifen-induced hot flashes: a University of Rochester Cancer Center Community Clinical Oncology Program study.

Authors:  K J Pandya; R F Raubertas; P J Flynn; H E Hynes; R J Rosenbluth; J J Kirshner; H I Pierce; V Dragalin; G R Morrow
Journal:  Ann Intern Med       Date:  2000-05-16       Impact factor: 25.391

Review 5.  Nonhormonal therapies for menopausal hot flashes: systematic review and meta-analysis.

Authors:  Heidi D Nelson; Kimberly K Vesco; Elizabeth Haney; Rongwei Fu; Anne Nedrow; Jill Miller; Christina Nicolaidis; Miranda Walker; Linda Humphrey
Journal:  JAMA       Date:  2006-05-03       Impact factor: 56.272

6.  Minimal decrease in hot flashes desired by postmenopausal women in family practice.

Authors:  Debra A Butt; Linda Y R Deng; Jacqueline E Lewis; Michael Lock
Journal:  Menopause       Date:  2007 Mar-Apr       Impact factor: 2.953

7.  Approach to the patient with menopausal symptoms.

Authors:  Kathryn Ann Martin; Joann E Manson
Journal:  J Clin Endocrinol Metab       Date:  2008-12       Impact factor: 5.958

Review 8.  Symptoms of menopause: hot flushes.

Authors:  Nanette Santoro
Journal:  Clin Obstet Gynecol       Date:  2008-09       Impact factor: 2.190

Review 9.  Hormone replacement therapy: real concerns and false alarms.

Authors:  Avrum Z Bluming; Carol Tavris
Journal:  Cancer J       Date:  2009 Mar-Apr       Impact factor: 3.360

10.  Revisiting the duration of vasomotor symptoms of menopause: a meta-analysis.

Authors:  Mary C Politi; Mark D Schleinitz; Nananda F Col
Journal:  J Gen Intern Med       Date:  2008-06-03       Impact factor: 5.128

View more
  2 in total

1.  The Relative Burden of Menopausal and Postmenopausal Symptoms versus Other Major Conditions: A Retrospective Analysis of the Medical Expenditure Panel Survey Data.

Authors:  Annlouise R Assaf; Andrew G Bushmakin; Nina Joyce; Michael J Louie; Michael Flores; Margaret Moffatt
Journal:  Am Health Drug Benefits       Date:  2017-09

2.  Economic Evaluation of Population-Based BRCA1/BRCA2 Mutation Testing across Multiple Countries and Health Systems.

Authors:  Ranjit Manchanda; Li Sun; Shreeya Patel; Olivia Evans; Janneke Wilschut; Ana Carolina De Freitas Lopes; Faiza Gaba; Adam Brentnall; Stephen Duffy; Bin Cui; Patricia Coelho De Soarez; Zakir Husain; John Hopper; Zia Sadique; Asima Mukhopadhyay; Li Yang; Johannes Berkhof; Rosa Legood
Journal:  Cancers (Basel)       Date:  2020-07-17       Impact factor: 6.639

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.